POLITICO @politico
Pfizer and BioNTech said they plan to submit data to the FDA for three doses of their Covid-19 vaccine for children ages 6 months to 5 years old. Three doses of the vaccine appeared to reduce cases of symptomatic Covid-19 by 80.3% among the youngest kids. https://t.co/zehKd35AgL — PolitiTweet.org